Government client
ALGAD BIOPROCESS
Development of bioprocessing technology
Filings
9
Filed by
1
Reported in-house
—
Reported by firms
—
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2019 to 2020
Filings
9 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
1st Quarter - Termination (No Activity) 1st Quarter 2020
|
MR. AMIR GOULART SCHARIF | — reported |
|
1st Quarter - Termination (No Activity)replaced 1st Quarter 2020
|
MR. AMIR GOULART SCHARIF | — reported |
|
3rd Quarter - Termination 3rd Quarter 2019
|
MR. AMIR GOULART SCHARIF | — reported |
|
4th Quarter - Report 4th Quarter 2019
|
MR. AMIR GOULART SCHARIF | — reported |
|
3rd Quarter - Reportreplaced 3rd Quarter 2019
|
MR. AMIR GOULART SCHARIF | — reported |
|
3rd Quarter - Termination (No Activity)replaced 3rd Quarter 2019
|
MR. AMIR GOULART SCHARIF | — reported |
|
2nd Quarter - Amendment 2nd Quarter 2019
|
MR. AMIR GOULART SCHARIF | — reported |
|
2nd Quarter - Reportreplaced 2nd Quarter 2019
|
MR. AMIR GOULART SCHARIF | — reported |
|
Registration 2nd Quarter 2019
|
MR. AMIR GOULART SCHARIF | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| MR. AMIR GOULART SCHARIF | 4 | — |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Science/Technology | SCI | 4 |
| Copyright/Patent/Trademark | CPT | 3 |
| Energy/Nuclear | ENG | 3 |
| Fuel/Gas/Oil | FUE | 3 |
| Environment/Superfund | ENV | 2 |
| Agriculture | AGR | 2 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.